Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fluorine-18 flotufolastat - Blue Earth Diagnostics

Next Previous
X
Search
Drug Profile

Fluorine-18 flotufolastat - Blue Earth Diagnostics

Alternative Names: (18F)-rhPSMA-7.3; 18F-rhPSMA-7.3; F-18-rhPSMA-7.3; Flotufolastat F-18 Gallium; Flotufolastat-F-18; Fluorine F 18 radiohybrid PSMA-7.3; Fluorine F 18 rhPSMA-7.3; Fluorine-18 rhPSMA-7.3; POSLUMA; radiohybrid PSMA-targeted PET imaging agent; rhPSMA; rhPSMA-7.3 (18F)

Latest Information Update: 13 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NYU Langone Health; Technical University Munich
  • Developer Blue Earth Diagnostics
  • Class Antineoplastics; Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Positron-emission tomography enhancers; Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Prostate cancer

Most Recent Events

  • 09 Jun 2024 Efficacy and adverse events data from the phase II trial in Prostate cancer released by Blue Earth Diagnostics
  • 25 Jan 2024 Efficacy data from phase III SPOTLIGHT trial in Prostate cancer presented at the 2024 Genitourinary Cancers Symposium (ASCO-GeCS-2024)
  • 25 Jan 2024 Efficacy data from phase III SPOTLIGHT trial in Prostate cancer released by Blue Earth Diagnostics

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top